KCNH2 Gene Short QT Syndrome Type 1 Genetic Test
Test Name: KCNH2 Gene Short QT Syndrome Type 1 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Cardiovascular Pneumology Disorders
Doctor: Cardiologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for KCNH2 Gene Short QT Syndrome Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNH2 Gene Short QT Syndrome Type 1 NGS Genetic DNA Test gene KCNH2
Test Details
The KCNH2 gene is associated with a condition called Short QT Syndrome Type 1 (SQT1). SQT1 is a rare genetic disorder that affects the electrical system of the heart, leading to abnormally short QT intervals on an electrocardiogram (ECG). This can increase the risk of dangerous arrhythmias, such as ventricular fibrillation and sudden cardiac arrest.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or the entire genome. In the context of SQT1, NGS genetic testing can be used to identify mutations or variations in the KCNH2 gene that may be responsible for the condition.
The genetic test involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology, which can detect variations in the KCNH2 gene. The results of the test can help confirm a diagnosis of SQT1 and guide treatment decisions.
It is important to note that genetic testing for SQT1 and other genetic disorders should be conducted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can interpret the results and provide appropriate counseling and management recommendations.
| Test Name | KCNH2 Gene Short QT syndrome type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for KCNH2 Gene Short QT syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KCNH2 Gene Short QT syndrome type 1 NGS Genetic DNA Test gene KCNH2 |
| Test Details |
The KCNH2 gene is associated with a condition called Short QT syndrome type 1 (SQT1). SQT1 is a rare genetic disorder that affects the electrical system of the heart, leading to abnormally short QT intervals on an electrocardiogram (ECG). This can increase the risk of dangerous arrhythmias, such as ventricular fibrillation and sudden cardiac arrest. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes or the entire genome. In the context of SQT1, NGS genetic testing can be used to identify mutations or variations in the KCNH2 gene that may be responsible for the condition. The genetic test involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology, which can detect variations in the KCNH2 gene. The results of the test can help confirm a diagnosis of SQT1 and guide treatment decisions. It is important to note that genetic testing for SQT1 and other genetic disorders should be conducted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can interpret the results and provide appropriate counseling and management recommendations. |
